VivoSeq
Other

Serratus Anterior Plane Block

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Serratus Anterior Plane Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

13/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

16

clinical trials

Completed8 · 50%
Unknown status3 · 19%
Withdrawn2 · 13%
Recruiting2 · 13%
Not yet recruiting1 · 6%

Trial Activity

16 trials

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block
Not yet recruiting··Phase 4·NCT06300099·126 enrolled
Serratus Anterior Plane Block in Pediatric Patients
Completed··N/A·NCT04444635·70 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)